{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:07:37Z","timestamp":1789142857775,"version":"build-2803163510"},"reference-count":42,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Invest Med"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ocular myasthenia gravis is an acquired autoimmune disorder primarily manifesting clinically as ptosis, diplopia, ocular muscle paralysis, and restricted ocular motility. However, its clinical presentation overlaps with multiple ocular pathologies, leading to frequent misdiagnosis in clinical practice and adversely affecting patient prognosis. Hence, we conducted a systematic review and analysis of relevant literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      From 1 January 2020 to 31 August 2025, three databases (PubMed, Web of Science and China National Knowledge Infrastructure) were searched. This study focused on ocular myasthenia gravis, incorporating neuromuscular disorders presenting with ocular abnormalities. Keywords were selected based on disease guidelines and common clinical scenarios (frequent differential diagnoses or misdiagnoses), and the keywords\n                      <jats:italic toggle=\"yes\">ocular myasthenia gravis<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">myasthenia gravis<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">motor nerve paralysis<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">ptosis<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">diabetic eye muscle paralysis<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">thyroid-associated ophthalmopathy<\/jats:italic>\n                      were ultimately selected. Eight studies published prior to 2020 were identified. Despite their age, these studies were included in the present review due to their relevance to the study's scope and their value for scholarly discussion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Ocular myasthenia gravis is caused by autoantibody-mediated damage to the neuromuscular junction and impaired signal transmission, typically presenting with ptosis, diplopia, and restricted eye movements. Due to the lack of a diagnostic gold standard, ocular myasthenia gravis is easily confused with oculomotor nerve palsy, ptosis, diabetic ophthalmoplegia, and thyroid-associated ophthalmopathy, leading to misdiagnosis or missed diagnosis. This may delay treatment or allow progression to generalized myasthenia gravis. Additionally, personalized treatment is required for specific populations with myasthenia gravis. Adolescents with ocular myasthenia gravis require greater caution in medication use, where traditional Chinese medicine offers a potential alternative for children with drug restrictions. Pregnant patients with myasthenia gravis require assessment of delivery methods and anesthesia risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The diagnosis of ocular myasthenia gravis remains challenging, requiring differentiation from multiple similar conditions to avoid misdiagnosis and disease progression. Additionally, individualized treatment for patients with myasthenia gravis in special populations, such as children and pregnant women, is crucial. For ocular myasthenia gravis, optimizing diagnostic criteria, achieving early differential diagnosis, and exploring safer and more effective therapeutic agents are urgent issues that need to be addressed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/cim-2025-0194","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:53:24Z","timestamp":1787676804000},"page":"31-39","source":"Crossref","is-referenced-by-count":0,"title":["Clinical research on ocular myasthenia gravis and related neuromuscular disorders: A systematic review and overview"],"prefix":"10.3138","volume":"49","author":[{"given":"MengYu","family":"Wang","sequence":"first","affiliation":[{"name":"Myasthenia gravis department of Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhaoYuan","family":"Sheng","sequence":"additional","affiliation":[{"name":"Myasthenia gravis department of Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"issue":"03","key":"e_1_3_10_2_2","first-page":"338","article-title":"Research progress on the correlation between myasthenia gravis and other autoimmune diseases","volume":"30","author":"Wu H","year":"2022","unstructured":"Wu H, Xiao X. Research progress on the correlation between myasthenia gravis and other autoimmune diseases. Chin Clin Neurosci. 2022;30(03):338\u201344. https:\/\/doi.org\/10.3969\/j.issn.1008-0678.2022.3.zglcsjkx202203016","journal-title":"Chin Clin Neurosci"},{"issue":"02","key":"e_1_3_10_3_2","first-page":"232","article-title":"Progress on the mechanism of Chinese medicine in the treatment of experimental autoimmune myasthenia gravis[J]","volume":"38","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Wang B, Lu Z, . Progress on the mechanism of Chinese medicine in the treatment of experimental autoimmune myasthenia gravis[J]. J Changchun Univ Tradit Chin Med. 2022;38(02):232\u20136. https:\/\/doi.org\/10.13463\/j.cnki.cczyy.2022.02.027","journal-title":"J Changchun Univ Tradit Chin Med"},{"issue":"2","key":"e_1_3_10_4_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ncl.2018.01.003","article-title":"Ocular myasthenia","volume":"36","author":"Al-Haidar M","year":"2018","unstructured":"Al-Haidar M, Benatar M, Kaminski HJ. Ocular myasthenia. Neurol Clin. 2018;36(2):241\u201351. https:\/\/doi.org\/10.1016\/j.ncl.2018.01.003","journal-title":"Neurol Clin"},{"issue":"2","key":"e_1_3_10_5_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3949\/ccjm.90a.22017","article-title":"Myasthenia gravis: frequently asked questions","volume":"90","author":"Morren JA","year":"2023","unstructured":"Morren JA, Li Y. Myasthenia gravis: frequently asked questions. Cleve Clin J Med. 2023;90(2):103\u201313. https:\/\/doi.org\/10.3949\/ccjm.90a.22017","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"e_1_3_10_6_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08164622.2022.2029683","article-title":"Ocular myasthenia gravis: a review and practical guide for clinicians","volume":"105","author":"Shuey NH","year":"2022","unstructured":"Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022;105(2):205\u201313. https:\/\/doi.org\/10.1080\/08164622.2022.2029683","journal-title":"Clin Exp Optom"},{"key":"e_1_3_10_7_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/EB.S389629","article-title":"Ocular myasthenia gravis: a current overview","volume":"15","author":"Behbehani R","year":"2023","unstructured":"Behbehani R. Ocular myasthenia gravis: a current overview. Eye Brain. 2023;15:1\u201313. https:\/\/doi.org\/10.2147\/EB.S389629","journal-title":"Eye Brain"},{"key":"e_1_3_10_8_2","doi-asserted-by":"crossref","first-page":"1110499","DOI":"10.3389\/fimmu.2023.1110499","article-title":"Inflammation and autoimmune myasthenia gravis","volume":"14","author":"Huda R","year":"2023","unstructured":"Huda R. Inflammation and autoimmune myasthenia gravis. Front Immunol. 2023;14:1110499. https:\/\/doi.org\/10.3389\/fimmu.2023.1110499","journal-title":"Front Immunol"},{"issue":"02","key":"e_1_3_10_9_2","first-page":"174","article-title":"Acupuncture combined with electroacupuncture and transcutaneous electrical stimulation of acupoints in the treatment of motor nerve palsy.1 [J]","volume":"35","author":"Fu B","year":"2025","unstructured":"Fu B, Luo N, Fang J. Acupuncture combined with electroacupuncture and transcutaneous electrical stimulation of acupoints in the treatment of motor nerve palsy.1 [J]. Chin J Ophthalmol. 2025;35(02):174\u20136. 10.13444\/j.cnki.zgzyykzz.2025.02.014","journal-title":"Chin J Ophthalmol"},{"issue":"1","key":"e_1_3_10_10_2","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1038\/s41598-025-91470-6","article-title":"Unusual presentations of myasthenia gravis and misdiagnosis","volume":"15","author":"Oguz-Akarsu E","year":"2025","unstructured":"Oguz-Akarsu E, Lazrak SEH, Gullu G, . Unusual presentations of myasthenia gravis and misdiagnosis. Sci Rep. 2025;15(1):7516. https:\/\/doi.org\/10.1038\/s41598-025-91470-6","journal-title":"Sci Rep"},{"issue":"9143","key":"e_1_3_10_11_2","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0140-6736(05)79896-2","article-title":"Myasthenic crisis after botulinum toxin","volume":"352","author":"Borodic G","year":"1998","unstructured":"Borodic G. Myasthenic crisis after botulinum toxin. Lancet. 1998;352(9143):1832. https:\/\/doi.org\/10.1016\/S0140-6736(05)79896-2","journal-title":"Lancet"},{"issue":"8","key":"e_1_3_10_12_2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/jdv.19115","article-title":"Do not forget about myasthenia gravis when performing botulinum toxin injections","volume":"37","author":"Dell'Antonia M","year":"2023","unstructured":"Dell'Antonia M, Mugheddu C, Ferreli C, . Do not forget about myasthenia gravis when performing botulinum toxin injections. J Eur Acad Dermatol Venereol. 2023;37(8):1070\u20131. https:\/\/doi.org\/10.1111\/jdv.19115","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"e_1_3_10_13_2","first-page":"424","article-title":"Distribution of etiology and clinical characteristics of 537 patients with ptosis attending the Department of Neurology","volume":"33","author":"Sun X","year":"2024","unstructured":"Sun X, Cui S, Wang J. Distribution of etiology and clinical characteristics of 537 patients with ptosis attending the Department of Neurology. Ophthalmology. 2024;33(6):424\u20138. https:\/\/doi.org\/10.13281\/j.cnki.issn.1004-4469.2024.06.004","journal-title":"Ophthalmology"},{"issue":"1","key":"e_1_3_10_14_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/11206721221107300","article-title":"Low probability of myasthenia gravis in patients presenting to neuro-ophthalmology clinic for evaluation of isolated ptosis","volume":"33","author":"Donaldson L","year":"2023","unstructured":"Donaldson L, Issa M, Dezard V, . Low probability of myasthenia gravis in patients presenting to neuro-ophthalmology clinic for evaluation of isolated ptosis. Eur J Ophthalmol. 2023;33(1):524\u20139. https:\/\/doi.org\/10.1177\/11206721221107300","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"e_1_3_10_15_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3233\/JND-230023","article-title":"Eye muscle MRI in myasthenia gravis and other neuromuscular disorders[J]","volume":"10","author":"Keene KR","year":"2023","unstructured":"Keene KR, Notting IC, Verschuuren JJGM, . Eye muscle MRI in myasthenia gravis and other neuromuscular disorders[J]. J Neuromuscul Dis. 2023;10(5):869\u201383. https:\/\/doi.org\/10.3233\/JND-230023","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"e_1_3_10_16_2","first-page":"215","article-title":"Misdiagnosis of ocular myasthenia gravis as diabetic ophthalmoplegia.1 [J]","volume":"25","author":"Xue Y","year":"2018","unstructured":"Xue Y, Zhang T, Chang M, . Misdiagnosis of ocular myasthenia gravis as diabetic ophthalmoplegia.1 [J]. Stroke Neurol Dis. 2018;25(2):215\u20136. https:\/\/doi.org\/10.3969\/j.issn.1007-0478.2018.02.025.","journal-title":"Stroke Neurol Dis"},{"issue":"12","key":"e_1_3_10_17_2","first-page":"1117","article-title":"Myasthenia gravis with multiple misdiagnoses of diabetic ocular myocardial palsy.1 case report","volume":"37","author":"Gan L","year":"2020","unstructured":"Gan L, Miao J, Jiang W, . Myasthenia gravis with multiple misdiagnoses of diabetic ocular myocardial palsy.1 case report. J Stroke Neurol Dis. 2020;37(12):1117\u20138. https:\/\/doi.org\/10.19845\/j.cnki.zfysjjbzz.2020.0533","journal-title":"J Stroke Neurol Dis"},{"issue":"04","key":"e_1_3_10_18_2","first-page":"496","article-title":"Clinical Characteristics and Inflammatory Factors in Thyroid-Associated Ophthalmopathy: Research Progress [J]","volume":"50","author":"Li Xiaomei","year":"2025","unstructured":"Li Xiaomei, Wang Xiaolei, Huang Xinyue, . Clinical Characteristics and Inflammatory Factors in Thyroid-Associated Ophthalmopathy: Research Progress [J]. Journal of Chongqing Medical University, 2025;50(04):496\u2013500. https:\/\/doi.org\/10.13406\/j.cnki.cyxb.003774.","journal-title":"Journal of Chongqing Medical University"},{"issue":"16","key":"e_1_3_10_19_2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' Disease","volume":"375","author":"Smith TJ","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves' Disease. N Engl J Med. 2016;375(16):1552\u201365. https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N Engl J Med"},{"issue":"1","key":"e_1_3_10_20_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/WCO.0000000000001339","article-title":"Thyroid eye disease and ocular myasthenia gravis","volume":"38","author":"Shabto JM","year":"2025","unstructured":"Shabto JM, Stevens S, Kazim M. Thyroid eye disease and ocular myasthenia gravis. Curr Opin Neurol. 2025;38(1):71\u201378. https:\/\/doi.org\/10.1097\/WCO.0000000000001339","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"e_1_3_10_21_2","first-page":"942","article-title":"Misdiagnosis of myasthenia gravis in thyroid-related ophthalmopathy combined with ocular myasthenia gravis","volume":"36","author":"Yang Y","year":"2021","unstructured":"Yang Y, Chen F, Huang Z, . Misdiagnosis of myasthenia gravis in thyroid-related ophthalmopathy combined with ocular myasthenia gravis. J Ophthalmol. 2021;36(11):942\u20136. https:\/\/doi.org\/10.3978\/j.issn.1000-4432.2021.10.01","journal-title":"J Ophthalmol"},{"issue":"10","key":"e_1_3_10_22_2","first-page":"1094","article-title":"Progress in the diagnosis and treatment of thyroid-related ophthalmopathy combined with myasthenia gravis","volume":"44","author":"Li Y","year":"2023","unstructured":"Li Y, He W. Progress in the diagnosis and treatment of thyroid-related ophthalmopathy combined with myasthenia gravis. Sichuan Medicine. 2023;44(10):1094\u20138. https:\/\/doi.org\/10.16252\/j.cnki.issn1004-0501-2023.10.018","journal-title":"Sichuan Medicine"},{"key":"e_1_3_10_23_2","doi-asserted-by":"crossref","first-page":"1388476","DOI":"10.3389\/fmolb.2024.1388476","article-title":"Non-coding RNA and its network in the pathogenesis of myasthenia gravis","volume":"11","author":"Wang F","year":"2024","unstructured":"Wang F, Mei X, Yang Y, . Non-coding RNA and its network in the pathogenesis of myasthenia gravis. Front Mol Biosci. 2024;11:1388476. https:\/\/doi.org\/10.3389\/fmolb.2024.1388476","journal-title":"Front Mol Biosci"},{"key":"e_1_3_10_24_2","doi-asserted-by":"crossref","first-page":"175628642312132","DOI":"10.1177\/17562864231213240","article-title":"Guideline for the management of myasthenic syndromes","volume":"16","author":"Wiendl H","year":"2023","unstructured":"Wiendl H, Abicht A, Chan A, . Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 2023;16:17562864231213240. https:\/\/doi.org\/10.1177\/17562864231213240","journal-title":"Ther Adv Neurol Disord"},{"issue":"06","key":"e_1_3_10_25_2","first-page":"455","article-title":"Clinical Characteristics and Outcomes of Ocular Myasthenia Gravis: A Single-Center Study [J]","volume":"24","author":"Sun Ping","year":"2024","unstructured":"Sun Ping, Feng Chao-yi, Chen Qian, . Clinical Characteristics and Outcomes of Ocular Myasthenia Gravis: A Single-Center Study [J]. Chinese Journal of Ophthalmology, Otology, and Rhinology. 2024;24(06):455\u201360. https:\/\/doi.org\/10.14166\/j.issn.1671-2420.2024.06.002","journal-title":"Chinese Journal of Ophthalmology, Otology, and Rhinology"},{"issue":"6","key":"e_1_3_10_26_2","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/jcsm.13089","article-title":"Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis[J]","volume":"13","author":"Keene KR","year":"2022","unstructured":"Keene KR, Kan HE, van der Meeren S, . Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis[J]. J Cachexia Sarcopenia Muscle. 2022;13(6):2820\u201334. https:\/\/doi.org\/10.1002\/jcsm.13089","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"19","key":"e_1_3_10_27_2","first-page":"115","article-title":"Research progress on the detection method of oculomotor myasthenia gravis","volume":"62","author":"XU Z","year":"2024","unstructured":"XU Z, WANG M. Research progress on the detection method of oculomotor myasthenia gravis[J]. China Modern Physician. 2024;62(19):115\u20139. https:\/\/doi.org\/10. 3978\/j. issn. 1000-4432. 2021. 07. 01.","journal-title":"China Modern Physician"},{"issue":"3","key":"e_1_3_10_28_2","first-page":"e56337","article-title":"Ocular myasthenia gravis as unilateral ptosis and external ophthalmoplegia: a case report","volume":"16","author":"Tanveer S","year":"2024","unstructured":"Tanveer S, Tahir A, Ahmad O, . Ocular myasthenia gravis as unilateral ptosis and external ophthalmoplegia: a case report. Cureus. 2024;16(3):e56337. https:\/\/doi.org\/10.7759\/cureus.56337","journal-title":"Cureus"},{"key":"e_1_3_10_29_2","doi-asserted-by":"crossref","unstructured":"Cavalcante P Mantegazza R Antozzi C. Targeting autoimmune mechanisms by precision medicine in myasthenia gravis[J]. Front Immunol. 2024;15:1404191. https:\/\/doi.org\/10.3389\/fimmu.2024.1404191","DOI":"10.3389\/fimmu.2024.1404191"},{"issue":"2","key":"e_1_3_10_30_2","doi-asserted-by":"crossref","first-page":"e31972","DOI":"10.1097\/MD.0000000000031972","article-title":"Ophthalmologic clinical features of ocular myasthenia gravis","volume":"102","author":"Kim D-H","year":"2023","unstructured":"Kim D-H, Roh HC, Oh SY. Ophthalmologic clinical features of ocular myasthenia gravis. Medicine (Baltimore). 2023;102(2):e31972. https:\/\/doi.org\/10.1097\/MD.0000000000031972","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"e_1_3_10_31_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNO.0000000000000270","article-title":"Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondary Generalization and Should It Be Offered to All Such Patients?","volume":"36","author":"Wong SH","year":"2016","unstructured":"Wong SH, Plant GT, Cornblath W. Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondary Generalization and Should It Be Offered to All Such Patients? J Neuroophthalmol. 2016;36(1):98\u2013102. https:\/\/doi.org\/10.1097\/WNO.0000000000000270","journal-title":"J Neuroophthalmol"},{"issue":"12","key":"e_1_3_10_32_2","first-page":"907","article-title":"Clinical Diagnosis and Treatment Expert Consensus on Ocular Myasthenia Gravis in China (2025) [J]","volume":"41","author":"Expert Group of the Chinese Clinical Diagnosis and Treatment Expert Consensus on Ocular Myasthenia Gravis (2025), Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, Neuro-Ophthalmology Professional Committee of the Chinese Research Hospital Association","year":"2025","unstructured":"Expert Group of the Chinese Clinical Diagnosis and Treatment Expert Consensus on Ocular Myasthenia Gravis (2025), Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, Neuro-Ophthalmology Professional Committee of the Chinese Research Hospital Association, Lin Xuemei, Xu Quangang, Li Haifeng, Zhou Xiaolai, Song Honglu, Wei Shihui, Wu Songdi. Clinical Diagnosis and Treatment Expert Consensus on Ocular Myasthenia Gravis in China (2025) [J]. Chinese Journal of Retinal Diseases, 2025;41(12):907\u201321. https:\/\/doi.org\/10.3760\/cma.j.cn511434-20250707-00298","journal-title":"Chinese Journal of Retinal Diseases"},{"issue":"01","key":"e_1_3_10_33_2","first-page":"61","article-title":"Expert consensus on Chinese medicine treatment of thyroid-related eye diseases (Hubei)[J]","volume":"47","author":"Zuo X","year":"2025","unstructured":"Zuo X, Zhao Y, Xia F, . Expert consensus on Chinese medicine treatment of thyroid-related eye diseases (Hubei)[J]. Hubei J Tradit Chin Med. 2025;47(01):61\u20136. https:\/\/doi.org\/1000-0704(2025)01-0061-06","journal-title":"Hubei J Tradit Chin Med"},{"key":"e_1_3_10_34_2","first-page":"125","volume-title":"Acupuncture and Moxibustion Techniques [M]","author":"Wang Fuchun","year":"2016","unstructured":"Wang Fuchun, Ma Tieming, Jia Chunsheng, . Acupuncture and Moxibustion Techniques [M]. 4th ed. Beijing: China Traditional Chinese Medicine Press, 2016:125.","edition":"4"},{"issue":"6","key":"e_1_3_10_35_2","first-page":"578","article-title":"Progress of Chinese medicine in the treatment of ocular myasthenia gravis in adolescents","volume":"33","author":"Chen X","year":"2023","unstructured":"Chen X, Shang Q, Xu X, . Progress of Chinese medicine in the treatment of ocular myasthenia gravis in adolescents. Chin J Ophthalmol. 2023;33(6):578\u201381. https:\/\/doi.org\/10.13444\/j.cnki.zgzyykzz.2023.06.018.","journal-title":"Chin J Ophthalmol"},{"issue":"1","key":"e_1_3_10_36_2","first-page":"41","article-title":"Expert Consensus on Integrated Diagnosis and Treatment of Myasthenia Gravis Based on Shanghai School of Traditional Chinese Medicine Characteristics [J]","volume":"58","author":"Sheng Zhaoyuan","year":"2024","unstructured":"Sheng Zhaoyuan, Chen Jian, Ying Rujiong, . Expert Consensus on Integrated Diagnosis and Treatment of Myasthenia Gravis Based on Shanghai School of Traditional Chinese Medicine Characteristics [J]. Shanghai Journal of Traditional Chinese Medicine, 2024;58(S1):41\u20137. https:\/\/doi.org\/10.16305\/j.1007-1334.2024.08","journal-title":"Shanghai Journal of Traditional Chinese Medicine"},{"issue":"1","key":"e_1_3_10_37_2","first-page":"55","article-title":"Expert Consensus on the Integrated Chinese and Western Medicine Comprehensive Management Model for Myasthenia Gravis [J]","volume":"58","author":"Sheng Zhaoyuan","year":"2024","unstructured":"Sheng Zhaoyuan, Shen Jie, Dong Yun, . Expert Consensus on the Integrated Chinese and Western Medicine Comprehensive Management Model for Myasthenia Gravis [J]. Journal of Traditional Chinese Medicine, 2024;58(S1):55\u201361. https:\/\/doi.org\/10.16305\/j.1007-1334.2024.10","journal-title":"Journal of Traditional Chinese Medicine"},{"issue":"2","key":"e_1_3_10_38_2","first-page":"219","article-title":"A case of labor analgesia for myasthenia gravis combined with ocular myasthenia gravis in pregnancy","volume":"39","author":"Deng L","year":"2023","unstructured":"Deng L, Wang M. A case of labor analgesia for myasthenia gravis combined with ocular myasthenia gravis in pregnancy. J Clin Anesthesiol. 2023;39(2):219\u201320. https:\/\/doi.org\/10.12089\/jca.2023.02.024","journal-title":"J Clin Anesthesiol"},{"issue":"6","key":"e_1_3_10_39_2","first-page":"421","article-title":"Diagnosis and treatment of myasthenia gravis in pregnancy","volume":"26","author":"Shen J","year":"2010","unstructured":"Shen J, Li X. Diagnosis and treatment of myasthenia gravis in pregnancy. Chin J Pract Gynecol Obstet. 2010;26(6):421\u20134. https:\/\/doi.org\/CNKI:SUN:ZGSF.0.2010-06-010","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"4","key":"e_1_3_10_40_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis[J]","volume":"87","author":"Sanders DB","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, . International consensus guidance for management of myasthenia gravis[J]. Neurology. 2016;87(4):419\u201325. https:\/\/doi.org\/10.1212\/WNL.0000000000002790","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_10_41_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-024-04965-7","article-title":"Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis","volume":"22","author":"Peng Y","year":"2024","unstructured":"Peng Y, Yang H, Chen Q, . An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis. J Transl Med. 2024;22(1):183. https:\/\/doi.org\/10.1186\/s12967-024-04965-7","journal-title":"J Transl Med"},{"issue":"12","key":"e_1_3_10_42_2","first-page":"907","article-title":"Expert Group of the Chinese Clinical Diagnosis and Treatment Consensus on Ocular Myasthenia Gravis (2025), Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, Neuro-Ophthalmology Professional Committee of the Chinese Research Hospital Association. Chinese Clinical Diagnosis and Treatment Consensus on Ocular Myasthenia Gravis (2025) [J]","volume":"41","year":"2025","unstructured":"Expert Group of the Chinese Clinical Diagnosis and Treatment Consensus on Ocular Myasthenia Gravis (2025), Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, Neuro-Ophthalmology Professional Committee of the Chinese Research Hospital Association. Chinese Clinical Diagnosis and Treatment Consensus on Ocular Myasthenia Gravis (2025) [J]. Chinese Journal of Retinal Diseases. 2025;41(12):907\u201321. https:\/\/doi.org\/10.3760\/cma.j.cn511434-20250707-00298","journal-title":"Chinese Journal of Retinal Diseases"},{"issue":"1","key":"e_1_3_10_43_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09273972.2025.2517641","article-title":"Ocular Myasthenia Gravis following strabismus surgery and presenting as refractory strabismus","volume":"34","author":"Nagasubramanian V","year":"2026","unstructured":"Nagasubramanian V, Rajamani M, Ghaisas SP, Dandapani R. Ocular Myasthenia Gravis following strabismus surgery and presenting as refractory strabismus. Strabismus. 2026;34(1):103\u201310. https:\/\/doi.org\/10.1080\/09273972.2025.2517641","journal-title":"Strabismus"}],"container-title":["Clinical and Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/CIM-2025-0194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:20:13Z","timestamp":1789140013000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/CIM-2025-0194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.3138\/CIM-2025-0194"],"URL":"https:\/\/doi.org\/10.3138\/cim-2025-0194","relation":{},"ISSN":["1488-2353"],"issn-type":[{"value":"1488-2353","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}